Ping Zhao

4.3k total citations · 1 hit paper
52 papers, 3.2k citations indexed

About

Ping Zhao is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Molecular Biology. According to data from OpenAlex, Ping Zhao has authored 52 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 14 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Ping Zhao's work include Pharmacogenetics and Drug Metabolism (14 papers), Pharmaceutical studies and practices (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Ping Zhao is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Pharmaceutical studies and practices (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Ping Zhao collaborates with scholars based in United States, China and United Kingdom. Ping Zhao's co-authors include Shiew‐Mei Huang, Joseph Mulinare, Senlian Hong, Lee‐Yang Wong, Jon D. Erickson, Cynthia A. Moore, R. J. Berry, Jashvant D. Unadkat, Amin Rostami‐Hodjegan and Huang Sm and has published in prestigious journals such as New England Journal of Medicine, The Astrophysical Journal and Clinical Cancer Research.

In The Last Decade

Ping Zhao

50 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of Neural-Tube Defects with Folic Acid in China

1999 989 citations R. J. Berry, Jon D. Erickson et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Ping Zhao

Since Specialization

Citations

This map shows the geographic impact of Ping Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Zhao more than expected).

Fields of papers citing papers by Ping Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Zhao. The network helps show where Ping Zhao may publish in the future.

Co-authorship network of co-authors of Ping Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Zhao. A scholar is included among the top collaborators of Ping Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Zhao. Ping Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical features and prognostic factors of pediatric Langerhans cell histiocytosis: a single-center retrospective study 2025 ·Frontiers in Medicine ·(unknown), Liying Liu, Qi Wang, (unknown), Ping Zhao, (unknown), (unknown)	1
2	Deciphering the role of sphingolipid metabolism in the immune microenvironment and prognosis of esophageal cancer via single-cell sequencing and bulk data analysis 2024 ·Discover Oncology ·Rongzhang He, Jing Tang, (unknown), Tianchi Zhang, (unknown), Siqi Wei, Ping Zhao, (unknown), (unknown), (unknown)	0
3	Comparative diagnostic performance of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for differentiating clear cell and non-clear cell renal cell carcinoma 2023 ·European Radiology ·Ping Zhao, (unknown), (unknown), Nan Li, Xinghua Zhang, Jinfeng Li, Yukun Luo, Qiuyang Li	11
4	Involvement of microRNA-155 in the mechanism of electroacupuncture treatment effects on experimental autoimmune encephalomyelitis 2021 ·International Immunopharmacology ·Ping Zhao, (unknown), Xudong Han, Yanping Wang, (unknown), (unknown), (unknown), Ying Liu, Qingfei Kong, Lili Mu, Jinghua Wang, Wei Zhao, Guangyou Wang, Xijun Liu, Tongshuai Zhang, Yao Zhang, Bo Sun, (unknown), (unknown), Hulun Li	12
5	Current status of treatment for 2019 novel coronavirus pneumonia 2020 ·Zhonghua weishengwuxue he mianyixue zazhi ·(unknown), Ping Zhao, Zhongtian Qi	1
6	Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme 2020 ·Frontiers in Oncology ·Xudong Han, Donghua Wang, Ping Zhao, (unknown), (unknown), (unknown), Jiarui Zhao, Wei Zhao, Lili Mu, Jing‐Hua Wang, Hulun Li, Qingfei Kong, Junwei Han	2
7	Early Detection of Treatment-Induced Mitotic Arrest Using Temporal Diffusion Magnetic Resonance Spectroscopy 2016 ·Neoplasia ·Xiaoyu Jiang, Hua Li, Ping Zhao, Jingping Xie, Dineo Khabele, Junzhong Xu, John C. Gore	21
8	Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling 2016 ·Drug Metabolism and Disposition ·Nitin Mehrotra, Atul Bhattaram, Justin Earp, (unknown), Kevin Krudys, Jung Eun Lee, (unknown), Jiaming Liu, Yeruk Mulugeta, Jiajie Yu, Ping Zhao, Vikram Sinha	58
9	FDA Approval: Blinatumomab 2015 ·Clinical Cancer Research ·Donna Przepiorka, Chia‐Wen Ko, Albert Deisseroth, Carolyn L. Yancey, (unknown), Haw-Jyh Chiu, Brenda J. Gehrke, (unknown), Robert C. Kane, Susan Kirshner, Nitin Mehrotra, Tiffany K. Ricks, Deborah H. Schmiel, Pengfei Song, Ping Zhao, Qing Zhou, Ann T. Farrell, Richard Pazdur	261
10	The Utility of Modeling and Simulation in Drug Development and Regulatory Review 2013 ·Journal of Pharmaceutical Sciences ·Shiew-Mei Huang, Nicholas M. P. King, Yaning Wang, Ping Zhao, Issam Zineh	160
11	Evaluation of Various Static and Dynamic Modeling Methods to Predict Clinical CYP3A Induction Using In Vitro CYP3A4 mRNA Induction Data 2013 ·Clinical Pharmacology & Therapeutics ·Heidi J. Einolf, (unknown), Odette A. Fahmi, Christopher R. Gibson, R. Scott Obach, Mohamad Shebley, (unknown), Michael Sinz, Jashvant D. Unadkat, L Zhang, Ping Zhao	73
12	A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women 2013 ·Drug Metabolism and Disposition ·Alice Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami‐Hodjegan, Nina Isoherranen, Jashvant D. Unadkat	71
13	Predicting Drug Interaction Potential With a Physiologically Based Pharmacokinetic Model: A Case Study of Telithromycin, a Time-Dependent CYP3A Inhibitor 2012 ·Clinical Pharmacology & Therapeutics ·(unknown), Ping Zhao, Eva Gil Berglund, K S Reynolds, (unknown), L J Lesko, S-M Huang	36
14	Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to Address Clinical Pharmacology Regulatory Questions 2012 ·Clinical Pharmacology & Therapeutics ·Ping Zhao, Malcolm Rowland, Huang Sm	165
15	Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation 2012 ·The Journal of Clinical Pharmacology ·Ping Zhao, Manuela de Lima Toccafondo Vieira, Joseph A. Grillo, Pengfei Song, (unknown), Jenny Zheng, Vikram Arya, Eva Gil Berglund, Arthur J. Atkinson, Yuichi Sugiyama, K. Sandy Pang, Kellie S. Reynolds, Nicholas M. P. King, Lei Zhang, Lawrence J. Lesko, Shiew‐Mei Huang	80
16	Dynamic absorption and desorption of polyphenols from Elaeagnus angustifolia L. by macroporous absorbent resins 2010 ·Journal of Northwest A&F University ·Ya Wang, (unknown), Ping Zhao, (unknown), (unknown)	1
17	Bioavailability Considerations in Evaluating Drug‐Drug Interactions Using the Population Pharmacokinetic Approach 2010 ·The Journal of Clinical Pharmacology ·John Duan, André J. Jackson, Ping Zhao	8
18	Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer 2009 ·Clinical Cancer Research ·Chirayu Shah, Todd W. Miller, Shelby K. Wyatt, Eliot T. McKinley, Maria G. Olivares, Violeta Sánchez, (unknown), Jason R. Buck, Ping Zhao, M. Sib Ansari, Ronald M. Baldwin, John C. Gore, Rachel Schiff, Carlos L. Arteaga, H. Charles Manning	69
19	Study of Screening and Effects of Effective Components on Hypoglycemic Activity of Polysaccharide from Mudan Cortex 2001 ·Zhongguo zhongyi jichu yixue zazhi ·(unknown), (unknown), Ping Zhao, (unknown), (unknown)	1
20	Prevention of Neural-Tube Defects with Folic Acid in China breakdown → 1999 ·New England Journal of Medicine ·R. J. Berry, (unknown), Jon D. Erickson, (unknown), Cynthia A. Moore, (unknown), Joseph Mulinare, Ping Zhao, Lee‐Yang Wong, (unknown), Senlian Hong, (unknown), (unknown), (unknown)	989

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact